Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Tyson Foods (TSN) to Post Q3 Earnings: What Awaits the Stock?

Published 08/03/2021, 10:59 PM
Updated 07/09/2023, 06:31 AM

Tyson Foods (NYSE:TSN), Inc. TSN is likely to register top- and bottom-line growth when it reports third-quarter fiscal 2021 results on Aug 9, before the opening bell. The Zacks Consensus Estimate for revenues is pegged at $11,199 million, which suggests a rise of 11.7% from the figure reported in the prior-year quarter.

The Zacks Consensus Estimate for the bottom line has gone up 12% in a week and is currently pegged at $1.77 per share. The estimate suggests growth of 26.4% from the year-ago quarter’s reported figure. Notably, this meat product giant’s bottom line has outpaced the Zacks Consensus Estimate by 20.7% in the last reported quarter. It has a trailing four-quarter earnings surprise of 39.1%, on average.

Key Aspects to Note

Tyson Foods’ top line is likely to have gained from growth in its retail business during the third quarter. The company’s retail business has been benefitting from favorable demand conditions as at-home consumption continues to prevail amid the pandemic. In the last earnings call, management highlighted that the company expects elevated demand in retail with volumes continuing to surpass pre-pandemic levels in Prepared Foods. The company has been ramping up production capacity to meet elevated demand conditions.

The company’s third-quarter performance is likely to have gained from sequential improvement in foodservice business. The foodservice channel is benefitting from rise in outdoor dining practices, thanks to easing of pandemic restrictions and mass vaccinations.

Tyson Foods’ e-commerce channel is seeing solid growth as more consumers are buying online amid the pandemic. Continuation of this trend is likely to have aided top-line growth in the to-be-reported quarter. The company is also likely to have gained from upsides such as strong brand portfolio, robust geographical reach and the ability to manufacture locally in international markets. It is also focused on higher protein production to cater to the rising demand for protein-packed food. The company is steadily expanding fresh prepared foods and plant-based offerings.

Headwinds emerging from incremental expenses associated with the pandemic are likely to have been a drag during the third quarter. Also, adverse impacts from a tight labor market as well as higher transportation and raw materials costs cannot be ignored.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Tyson Foods, Inc. Price, Consensus and EPS Surprise

Tyson Foods, Inc. price-consensus-eps-surprise-chart | Tyson Foods, Inc. Quote

What the Zacks Model Unveils

Our proven model predicts an earnings beat for Tyson Foods this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Tyson Foods has a Zacks Rank #3 and an Earnings ESP of +11.17%.

Other Stocks With Favorable Combination

Here are some more companies you may want to consider as our model shows that these have the right combination of elements to post an earnings beat:

Chewy (NYSE:CHWY) Inc. CHWY currently has an Earnings ESP of +20% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Darling Ingredients (NYSE:DAR) Inc. DAR currently has an Earnings ESP of +10.09% and a Zacks Rank #2.

Sprouts Farmers (NASDAQ:SFM) Market, Inc. SFM has an Earnings ESP of +2.95% and a Zacks Rank #3, at present.


Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Tyson Foods, Inc. (TSN): Free Stock Analysis Report

Darling Ingredients Inc. (DAR): Free Stock Analysis Report

Sprouts Farmers Market, Inc. (SFM): Free Stock Analysis Report

Chewy Inc. (CHWY): Free Stock Analysis Report

To read this article on Zacks.com click here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.